Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,670 | 205,194 | 88,334 | 60,241 | 137,658 |
| Marketable Securities | 281,701 | 175,685 | 154,484 | 197,572 | 16,000 |
| Receivables | 53,472 | 43,271 | 42,571 | 32,016 | 22,126 |
| Inventories | 1,940 | 547 | 910 | 6,703 | 6,640 |
| Other current assets | 27 | 3 | 46 | 18 | 204 |
| TOTAL | $438,980 | $452,953 | $314,875 | $329,497 | $208,132 |
| Non-Current Assets | |||||
| PPE Net | 114,223 | 112,785 | 114,264 | 129,597 | 133,004 |
| Intangibles | 0 | 0 | 0 | 14,475 | 14,977 |
| Other Non-Current Assets | 75,301 | 80,899 | 72,759 | 45,418 | 45,963 |
| TOTAL | $189,524 | $193,684 | $187,023 | $189,490 | $193,944 |
| Total Assets | $628,504 | $646,637 | $501,898 | $518,987 | $402,076 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,548 | 12,122 | 7,381 | 6,216 | 7,547 |
| Accrued Expenses | 55,671 | 48,204 | 46,838 | 43,602 | 35,705 |
| TOTAL | $76,727 | $67,952 | $61,754 | $57,134 | $50,644 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,597,550 | 1,447,826 | 939,732 | 985,284 | 921,270 |
| TOTAL | $1,597,538 | $1,447,811 | $939,718 | $985,263 | $921,251 |
| Total Liabilities | $1,674,265 | $1,515,763 | $1,001,472 | $1,042,397 | $971,895 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,059,836 | 1,047,354 | 1,028,111 | 984,965 | 945,255 |
| Common Shares | 105 | 104 | 101 | 98 | 91 |
| Retained earnings | -4,589,806 | -4,359,428 | -3,726,646 | -3,664,702 | -3,597,449 |
| Other shareholders' equity | 28,152 | 28,333 | 29,851 | 5,906 | 13,498 |
| TOTAL | $-1,045,761 | $-869,126 | $-499,574 | $-523,410 | $-569,819 |
| Total Liabilities And Equity | $628,504 | $646,637 | $501,898 | $518,987 | $402,076 |